N/A
Manufactured by Little Pharma, Inc.
871 FDA adverse event reports analyzed
Last updated: 2026-04-15
LIDOCAINE 5% is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Little Pharma, Inc.. The most commonly reported adverse reactions for LIDOCAINE 5% include NAUSEA, DRUG INEFFECTIVE, PAIN, HEADACHE, DIZZINESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LIDOCAINE 5%.
Out of 486 classified reports for LIDOCAINE 5%:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 871 FDA FAERS reports that mention LIDOCAINE 5%. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, DRUG INEFFECTIVE, PAIN, HEADACHE, DIZZINESS, HYPOTENSION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Little Pharma, Inc. in connection with LIDOCAINE 5%. Always verify the specific product and NDC with your pharmacist.